Ormeloxifene (sold under the trade names of Shaleli, Choice-7, Novex-DS, Centchroman and Centron) is one of the Selective Estrogen Receptor Modulators, or SERMs, a class of medication which acts on the human estrogen receptor.
It's best known as a non-steroidal oral contraceptive which is taken once per week. In India, ormeloxifene has been available for birth control since the early 1990s. With current sales in the region of 30 million pills per year. (source Current Science 115(9):1638)
Its precise mechanism of action is unknown, but is believed to be linked to its ability to cause asynchrony in the menstrual cycle.
Ideas for new topics, and suggested additions / corrections for old ones, are always welcome.
If you have skills or interests in a particular field, and have suggestions for Wikenigma, get in touch !
Or, if you'd like to become a regular contributor . . . request a login password. Registered users can edit the entire content of the site, and also create new pages.
( The 'Notes for contributors' section in the main menu has further information and guidelines etc.)
You are currently viewing an auto-translated version of Wikenigma
Please be aware that no automatic translation engines are 100% accurate, and so the auto-translated content will very probably feature errors and omissions.
Nevertheless, Wikenigma hopes that the translated content will help to attract a wider global audience.